4Q1

fumitremorgen B

Created:	2015-05-07
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 4Q1 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	4
Bond Count	72
Aromatic Bond Count	10

2D diagram of 4Q1

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	fumitremorgen B
Synonyms	(5aR,6S,12S,14aS)-5a,6-dihydroxy-9-methoxy-11-(3-methylbut-2-en-1-yl)-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione
Systematic Name (OpenEye OEToolkits)	n/a
Formula	C₂₇ H₃₃ N₃ O₅
Molecular Weight	479.568
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	COc1ccc2c(c1)n(c5c2C(C4(C(=O)N3CCCC3C(N4C5\C=C(/C)C)=O)O)O)C\C=C(\C)C
SMILES	CACTVS	3.385	COc1ccc2c(c1)n(CC=C(C)C)c3[CH](C=C(C)C)N4C(=O)[CH]5CCCN5C(=O)[C]4(O)[CH](O)c23
SMILES	OpenEye OEToolkits	1.9.2	CC(=CCn1c2cc(ccc2c3c1C(N4C(=O)C5CCCN5C(=O)C4(C3O)O)C=C(C)C)OC)C
Canonical SMILES	CACTVS	3.385	COc1ccc2c(c1)n(CC=C(C)C)c3[C@H](C=C(C)C)N4C(=O)[C@@H]5CCCN5C(=O)[C@]4(O)[C@@H](O)c23
Canonical SMILES	OpenEye OEToolkits	1.9.2	CC(=CCn1c2cc(ccc2c3c1[C@@H](N4C(=O)[C@@H]5CCCN5C(=O)[C@@]4([C@H]3O)O)C=C(C)C)OC)C
InChI	InChI	1.03	InChI=1S/C27H33N3O5/c1-15(2)10-12-28-20-14-17(35-5)8-9-18(20)22-23(28)21(13-16(3)4)30-25(32)19-7-6-11-29(19)26(33)27(30,34)24(22)31/h8-10,13-14,19,21,24,31,34H,6-7,11-12H2,1-5H3/t19-,21-,24-,27+/m0/s1
InChIKey	InChI	1.03	WEIYXEFMCIRZHC-MWGWWEMPSA-N

Related Resource References

Resource Name	Reference
PubChem	105113
ChEMBL	CHEMBL3885413
ChEBI	CHEBI:64531

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.